These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

239 related items for PubMed ID: 28440069

  • 1.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 2. Recurrence and mortality after first venous thromboembolism in a large population-based cohort.
    Arshad N, Bjøri E, Hindberg K, Isaksen T, Hansen JB, Braekkan SK.
    J Thromb Haemost; 2017 Feb; 15(2):295-303. PubMed ID: 27943560
    [Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6. Impact of incident myocardial infarction on the risk of venous thromboembolism: the Tromsø Study.
    Rinde LB, Lind C, Småbrekke B, Njølstad I, Mathiesen EB, Wilsgaard T, Løchen ML, Hald EM, Vik A, Braekkan SK, Hansen JB.
    J Thromb Haemost; 2016 Jun; 14(6):1183-91. PubMed ID: 27061154
    [Abstract] [Full Text] [Related]

  • 7. Omega-3 fatty acids predict recurrent venous thromboembolism or total mortality in elderly patients with acute venous thromboembolism.
    Reiner MF, Stivala S, Limacher A, Bonetti NR, Méan M, Egloff M, Rodondi N, Aujesky D, von Schacky C, Lüscher TF, Camici GG, Beer JH.
    J Thromb Haemost; 2017 Jan; 15(1):47-56. PubMed ID: 27790827
    [Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10. The long-term recurrence risk of patients with unprovoked venous thromboembolism: an observational cohort study.
    Kyrle PA, Kammer M, Eischer L, Weltermann A, Minar E, Hirschl M, Heinze G, Eichinger S.
    J Thromb Haemost; 2016 Dec; 14(12):2402-2409. PubMed ID: 27696701
    [Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12. Joint effects of prothrombotic genotypes and body height on the risk of venous thromboembolism: the Tromsø study.
    Horvei LD, Braekkan SK, Smith EN, Solomon T, Hindberg K, Frazer KA, Rosendaal FR, Hansen JB.
    J Thromb Haemost; 2018 Jan; 16(1):83-89. PubMed ID: 29094466
    [Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17. Long-term risk of venous thromboembolism recurrence after isolated superficial vein thrombosis.
    Galanaud JP, Sevestre MA, Pernod G, Kahn SR, Genty C, Terrisse H, Brisot D, Gillet JL, Quéré I, Bosson JL.
    J Thromb Haemost; 2017 Jun; 15(6):1123-1131. PubMed ID: 28317330
    [Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19. Platelet count measured prior to cancer development is a risk factor for future symptomatic venous thromboembolism: the Tromsø Study.
    Jensvoll H, Blix K, Brækkan SK, Hansen JB.
    PLoS One; 2014 Jun; 9(3):e92011. PubMed ID: 24642868
    [Abstract] [Full Text] [Related]

  • 20. Risk of recurrent venous thromboembolism after discontinuation of vitamin K antagonist treatment: a nested case-control study.
    Martinez C, Katholing A, Folkerts K, Cohen AT.
    J Thromb Haemost; 2016 Jul; 14(7):1374-83. PubMed ID: 27079164
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 12.